United Therapeutics Corporation (UTHR)
NASDAQ · Healthcare
United Therapeutics Corporation Shareholder Equity 2008–2025
United Therapeutics Corporation annual shareholder equity history from 2009 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- United Therapeutics Corporation shareholder equity as of December 31, 2025: 7.10B, a 10.12% increase year-over-year.
- United Therapeutics Corporation shareholder equity for 2025 were 7.10B, a 10.12% increase from 2024.
- United Therapeutics Corporation shareholder equity for 2024 were 6.44B, a 7.67% increase from 2023.
- United Therapeutics Corporation shareholder equity for 2023 were 5.98B, a 24.77% increase from 2022.
- United Therapeutics Corporation shareholder equity for 2022 were 4.80B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| United Therapeutics Corporation Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $7,096 |
| 2024 | $6,444 |
| 2023 | $5,985 |
| 2022 | $4,797 |
| 2021 | $3,959 |
| 2020 | $3,395 |
| 2019 | $2,780 |
| 2018 | $2,789 |
| 2017 | $2,102 |
| 2016 | $1,851 |
| 2015 | $1,589 |
| 2014 | $1,243 |
| 2013 | $1,259 |
| 2012 | $1,084 |
| 2011 | $948 |
United Therapeutics Corporation Shareholder Equity — FAQ
United Therapeutics Corporation (UTHR) shareholder equity over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see UTHR's shareholder equity history?
The chart and table above show United Therapeutics Corporation's shareholder equity by year and by quarter, including the growth rate.